Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
Johnson and Johnson
Farmers Insurance
Cantor Fitzgerald
US Department of Justice

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205772

« Back to Dashboard

NDA 205772 describes CALCIPOTRIENE, which is a drug marketed by Glenmark Pharms, Tolmar, Glenmark Pharms Inc, Fougera Pharms, G And W Labs Inc, Hi Tech Pharma, and Perrigo Israel, and is included in nine NDAs. It is available from eight suppliers. Additional details are available on the CALCIPOTRIENE profile page.

The generic ingredient in CALCIPOTRIENE is betamethasone dipropionate; calcipotriene hydrate. There are sixty-six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene hydrate profile page.
Summary for 205772
Applicant:Glenmark Pharms
Therapeutic Class:Dermatological Agents
Pharmacology for NDA: 205772
Ingredient-typeVitamin D
Suppliers and Packaging for NDA: 205772
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CALCIPOTRIENE calcipotriene CREAM;TOPICAL 205772 ANDA Glenmark Pharmaceuticals Inc.,USA 68462-501 68462-501-65 1 TUBE in 1 CARTON (68462-501-65) > 60 g in 1 TUBE
CALCIPOTRIENE calcipotriene CREAM;TOPICAL 205772 ANDA Glenmark Pharmaceuticals Inc.,USA 68462-501 68462-501-66 1 TUBE in 1 CARTON (68462-501-66) > 120 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.005%
Approval Date:Jun 9, 2015TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Daiichi Sankyo
Argus Health
US Department of Justice
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.